Schedule Your Appointment Today!
USAnaphylaxis Summit – Atlanta, GA: September 19th
Do you want to make a positive change about anaphylaxis education in your community? Then join Allergy & Asthma Network at its 2nd Annual USAnaphylaxis Summit in Atlanta on Friday, September 19th! This one-day regional event will bring together allergists, school nurses, nutritionists, asthma educators, pediatricians, FAACT-recognized support group leaders, parents of children with life-threatening allergies, and others to share resources, strategies and experiences to build a stronger community-based anaphylaxis network.
The event features nationally prominent physicians and anaphylaxis experts including our own Dr. Stanley Fineman. Presentations will be followed by interactive roundtable discussions, allowing attendees to dialogue with each other and develop action plans to build anaphylaxis awareness and preparedness in their communities.
To register for this free Summit, click here: Friday, September 19th, 2014 at Marriott Evergreen Conference Resort, Stone Mountain, GA.
New Treatment Options for Allergy Patients
Recently the FDA has approved several products for patients with seasonal allergic rhinitis. These tablets, which treat grass or ragweed pollen allergies, are used daily under the tongue and are called sub-lingual allergen immunotherapy (SLIT). They are indicated for allergy patients who have sensitivities to either grass or ragweed pollens, since each tablet only treats one allergen.
Although this therapy is a new option for allergy patients, as with any medical treatment, the benefits must be balanced with the potential risks. Speak with your Atlanta Allergy & Asthma physician to see if these tablets are recommended for the management of your allergies.
Participants Needed for Asthma Research Study
Atlanta Allergy & Asthma’s Research Department is looking for qualified participants for an asthma research study. We are looking for people with uncontrolled asthma. To be considered for this study, you must:
-Be between 18 and 75 years of age
-Have received an asthma diagnosis at least one year ago
-Be taking an inhaled Corticosteroid and a second controller medication for the last 6 months, with no dose changes to these medications in the 4 weeks prior to the study.
-Have asthma that is not controlled by these medications
All study-related visits, tests, and drugs will be provided at no cost. In addition, reimbursement for time and travel may be provided.
To learn more:
Stockbridge Research - 770 996-5354 or email firstname.lastname@example.org
Marietta Research - 770 592-4210 or email email@example.com
Sign Up for Our New Patient Newsletter
Subscribe to our new Allergy Update newsletter, and you'll get practice news, updates on the latest allergy and asthma research, and more.